IMMUNOLOGY OF HUMAN PLATELETS (HIV-1-ITP)

人类血小板的免疫学 (HIV-1-ITP)

• 批准号: 6718067
• 负责人: SIMON KARPATKIN
• 金额: $ 33.8万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 1992
• 资助国家: 美国
• 起止时间: 1992-07-01 至 2008-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6718067
• 关键词: HIV infections; NAD(P)H dehydrogenase; autoantibody; clinical research; cytolysis; flow cytometry; free radicals; genetically modified animals; granulocyte; human tissue; hydrogen peroxide; immune complex; immunohematology; laboratory mouse; leukotrienes; lipoxygenase; macrophage; platelet disorder; platelets; shear stress; thrombocytopenia

DESCRIPTION (provided by applicant): We have discovered a novel mechanism for platelet lysis and clearance in HIV-I-ITP patients, which is complement independent and induced by H202/free radicals. The Ab is directed against an immunodominant platelet GPIIla49-66 epitope and sequestered within serum immune complexes. Other Ab's against GPIIla do not have this effect. A rabbit Ab raised against GPIIla49-66 has the same effect. The mechanism of H202/free radical induction is via an apparent NADPH oxidase pathway in platelets since it is inoperative in NADPH oxidase deficient mice (p47phox(-/-) and gp91phox(-/-)) and dependent upon a functioning platelet 12-1ipoxygenase. I. Analyze the Presence of a Functioning NADPH Oxidase Pathway in Platelets. 2. Analyze the Mechanism of the Requirement of Platelet 12-Lipoxygenase for Ab-induced Platelet fragmentation. 3. Determine whether NADPH oxidase/ROS induced platelet fragmentation is a unique effect of anti- GPIIla49-66 Ab in HIV-I-ITP patients or a general mechanism for other platelet destructive disorders. 4. Determine whether anti-GPIIla49-66 is a result of molecular mimicry with antigen of infectious origin or its products.

描述（由申请人提供）：我们发现了HIV-I-ITP患者血小板溶解和清除的新机制，该机制不依赖补体，由H202/自由基诱导。这种抗体直接针对免疫优势血小板GPIIla49-66表位，并被隔离在血清免疫复合物中。其他抗GPIIla的抗体没有这种效果。抗GPIIla49-66的兔抗体也有同样的效果。H202/自由基诱导的机制是通过血小板中的NADPH氧化酶途径，因为它在NADPH氧化酶缺陷小鼠（p47phox（-/-）和gp91phox(-/-)）中不起作用，并依赖于血小板12-1氧合酶的功能。1 .分析血小板中功能性NADPH氧化酶途径的存在。血小板12-脂氧合酶对抗体诱导血小板破碎的作用机制分析。3. 确定NADPH氧化酶/ROS诱导的血小板破碎是抗GPIIla49-66 Ab在HIV-I-ITP患者中的独特作用，还是其他血小板破坏性疾病的一般机制。4. 确定抗gpiila49 -66是否是与感染源抗原或其产物分子模仿的结果。